Key takeaways

• AI amplifies brand and compliance risk, not just output, so marketing needs formal governance.

• You can borrow structures from NIST’s AI RMF and ISO/IEC 42001 instead of inventing policy from scratch.

• Guardrails need to cover data, truth, brand language, review tiers, and auditability.

• Healthcare marketing has additional non negotiables: HIPAA rules on PHI use and FDA oversight of drug promotion.

• A two lane workflow with clear roles and evidence first rules lets teams move fast without damaging brands.

AI tools have made it trivially easy for marketing teams to produce more content, more ideas, and more campaigns. They have also made it trivially easy to:

• Invent claims that sound plausible but are wrong

• Drift away from brand positioning and approved language

• Accidentally expose sensitive data

• Cross regulatory lines in healthcare and other regulated industries

Regulators are already treating AI as a risk surface, not a novelty. The FTC has launched enforcement actions against companies that make deceptive or unsubstantiated AI related claims and has been explicit that there is no AI exemption from existing advertising laws. Source: Federal Trade Commission

In healthcare, HIPAA’s Privacy Rule still requires patient authorization for most marketing uses of PHI, with only narrow exceptions and FDA’s Office of Prescription Drug Promotion (OPDP) continues to police drug promotion so it remains truthful, balanced, and accurately communicated. Source: U.S. Food and Drug Administration

Marketing cannot treat AI as “just a writing assistant.” It is a compliance and brand risk system that needs governance.

Start from existing AI governance frameworks

You do not have to invent AI governance from scratch. Two frameworks are particularly useful:

• NIST AI Risk Management Framework

  • Built around four core functions: Govern, Map, Measure, and Manage.

  • Gives you a way to define policy and accountability (Govern), understand AI use in context (Map), assess risks (Measure), and control them across the lifecycle (Manage).

• ISO/IEC 42001

  • The first AI management system standard, specifying requirements for establishing, implementing, maintaining, and continually improving an AI management system.

  • Focuses on topics like risk management, transparency, and oversight of third party AI tools.

At marketing scale, you are not trying to implement these standards line by line. You are using them to justify why you need clear roles, processes, and documentation around AI use.

Build an AI governance charter for marketing

Every marketing team needs a simple, written AI governance charter that people can point to when work gets hectic. At minimum it should define:

• Scope

  • Which teams and activities the policy covers (content, SEO, paid media, design, analytics).

• Approved use cases

  • Ideation, outlining, repurposing, summarizing client provided materials, QA checks, structured rewrites.

• Prohibited uses

  • Inventing performance claims, medical efficacy statements, legal interpretations, competitor allegations, or citations that do not exist.

  • Generating privacy or policy language without legal review.

• Data handling rules

  • Which AI tools are approved.

  • Rules for PHI, PII, and sensitive customer data (for example, never paste PHI into general consumer models; use only vetted enterprise tools with proper contracts).

• Review gates

  • When content can ship with marketing review only and when legal, compliance, or security must sign off.

• Escalation path

  • Who gets called when there is a question or an incident.

You can draft a first version with a model and refine it:

“Draft an AI Governance Charter for a marketing team in a regulated industry. Include scope, approved use cases, prohibited uses, data handling rules, review gates, and an escalation path.”

Then have legal and security approve or edit it.

Define roles with a simple RACI

Governance is meaningless if it is not clear who owns decisions. A RACI matrix gives you that clarity. Typical roles:

• Marketing and content

  • Responsible for prompts, drafts, and aligning work to brand and campaign goals.

• Brand

  • Accountable for voice, positioning, approved terms, and visual consistency.

• Legal and compliance

  • Accountable for regulatory risk, disclosures, and high risk content types.

• Security and privacy

  • Consulted on tool selection, data flows, and retention policies.

• Subject matter experts

  • Consulted for technical, clinical, or product accuracy.

You can generate a starting matrix:

“Create a RACI matrix for AI assisted marketing content: roles for marketing, legal or compliance, security, SMEs, and brand. Include approval checkpoints for webpages, ads, email, and social.”

Then adjust based on your actual team structure.

Guardrails that matter most in practice

You do not need a 50 page policy. You need a handful of guardrails that everyone understands.

Data guardrails

• Never paste PHI, PII, or sensitive customer data into general purpose LLMs.

• Use only approved tools with clear retention and training policies.

• Redact or synthesize examples when discussing real cases.

Truth guardrails

• Any factual or performance claim must map to a client source, public documentation, or a citation.

• Separate “ideas” or hypotheses from assertions in drafts.

• If evidence does not exist, rewrite as a bounded statement or remove it.

Brand guardrails

• Maintain a single source of truth for product names, modules, benefits, and differentiators.

• Define prohibited phrases (for example, “guaranteed results,” “no risk”) and regulated terms.

• Use AI to rephrase within that fence, not outside it.

Review guardrails

• Risk tier content:

  • Low risk: non claims educational blogs, thought leadership.

  • High risk: healthcare topics, security and compliance pages, pricing, comparison pages, ads, and email sequences that promise results.

• High risk content requires SME plus legal or compliance review before publishing.

Audit guardrails

• Log prompts and outputs for regulated or high risk content.

• Use version control and reviewer sign off for pages that could trigger FDA, FTC, or privacy scrutiny.

For individual drafts, you can even run a “red team” pass with AI before human review:

“Given this draft content (paste), produce a compliance and brand risk review: identify unverifiable claims, missing disclaimers, privacy risks, hallucination risk areas, and required citations or source links.”

Healthcare marketing: non negotiable examples

Healthcare is where AI governance failures become real liabilities.

• HIPAA

  • The HIPAA Privacy Rule generally requires authorization to use or disclose PHI for marketing, except for narrow face to face and nominal value gift exceptions. Source: HHS

  • AI tools must be treated as vendors and covered by appropriate agreements if they ever touch PHI.

• FDA and OPDP

  • OPDP’s mission is to ensure prescription drug promotion is truthful, balanced, and accurately communicated.

  • Recent enforcement waves have highlighted FDA’s use of AI and other tech enabled tools to monitor direct to consumer drug advertising.

For healthcare marketers, that means:

• Classifying any AI assisted content related to treatments, drugs, or specific conditions as high risk.

• Requiring medical, regulatory, and legal review before anything goes live.

• Maintaining strict templates for disclaimers, risk statements, and scoping language.

How we run AI internally so we do not damage brands

A practical internal model looks like this.

Approved use cases by tier

• Ideation and outlining from existing briefs.

• Repurposing client approved content into new formats.

• Summarizing long documents, research, or transcripts.

• QA checks for clarity, consistency, and missing questions.

• Structured rewrites into entity first, AI ready formats.

Prohibited use cases

• Inventing metrics, performance results, or ROI.

• Creating medical or legal interpretations.

• Making claims about competitors or market share without client provided proof.

• Fabricating citations or references.

• Drafting policy language without counsel review.

Two lane workflow

• Lane A (low risk)

  • Educational blogs, non claims SEO content, internal enablement.

  • Requires a single senior editor check for accuracy and brand alignment.

• Lane B (high risk)

  • Healthcare topics, pricing pages, security and compliance content, comparisons, ads, landing pages, and any content tied directly to regulated claims.

  • Requires SME review plus legal or compliance approval, with prompts and outputs logged.

Evidence first rule

• Every material claim is traced back to a source: client documents, official documentation, or a public reference.

• If no source exists, the claim is rewritten as a bounded statement (“many clients use this to…”) or removed entirely.

Brand consistency pack

• Controlled vocabulary and product entity map.

• Approved differentiators and proof points.

• Library of disclaimers and regulatory language by vertical.

• Example snippets that show the right tone and scoping.

This structure lets AI accelerate the work without letting it run the brand.

Next step: an AI Marketing Governance Sprint

If AI is already embedded in your marketing but there is no formal governance, you are relying on individual judgment in a high risk environment.

An AI Marketing Governance Sprint can compress the work: create a charter, a practical RACI, a risk tier approval workflow, and a content guardrails checklist tailored to your industry, including HIPAA focused controls for healthcare teams.

The goal is simple: ship faster with AI, without gambling your brand and compliance posture every time you hit publish.